Montelukast Accord (Montelukast Sodium)

Montelukast selectively blocks the cysteinyl leukotriene receptor CysLT1 on airway smooth‑muscle cells and inflammatory cells. By inhibiting leukotriene binding, it prevents bronchoconstriction, reduces vascular permeability, and limits eosinophil recruitment, thereby decreasing airway inflammation and hyper‑responsiveness.

The appropriate dose of Montelukast Accord is determined by the prescribing healthcare professional based on the patient’s age, condition, and clinical response. Standard dosing guidelines exist for different indications, but the exact regimen should be individualized by the prescriber.

The safety of Montelukast in pregnancy and lactation has not been definitively established, and it is classified as having an unknown pregnancy category. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the medication.

To place an order, submit an enquiry on the Montelukast Accord product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Montelukast belongs to the leukotriene receptor antagonist class, offering an oral alternative to inhaled corticosteroids or long‑acting beta‑agonists for asthma control. While inhaled steroids target broader inflammatory pathways, Montelukast specifically blocks leukotriene‑mediated effects, which can be advantageous for patients who prefer oral therapy or have aspirin‑exacerbated respiratory disease.

Montelukast Accord tablets should be stored at room temperature, below 25 °C, in their original blister pack or container. Protect the product from moisture, excessive heat and direct sunlight to maintain stability throughout its shelf life.

Montelukast Accord is taken orally as a tablet, swallowed whole with water. It may be taken with or without food, according to the prescriber’s instructions. Consistency in the time of day helps maintain steady drug levels.

Serious adverse events include angioedema, severe skin reactions such as Stevens‑Johnson syndrome, and neuropsychiatric effects like depression, mood swings or suicidal thoughts. Patients should seek immediate medical attention if they experience swelling of the face or lips, unusual skin eruptions, or significant changes in mood or behavior.

Montelukast Accord should be avoided in individuals with known hypersensitivity to montelukast or any component of the formulation. Caution is also advised for patients with severe hepatic impairment, and it is not recommended for use in children under the age approved for the specific indication without medical guidance.